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Radiation-attenuated (RA) schistosome larvae are potent stimulators of innate immune responses at the
skin site of exposure (pinna) that are likely to be important factors in the development of Th1-mediated
protective immunity. In addition to causing an influx of neutrophils, macrophages, and dendritic cells (DCs)
into the dermis, RA larvae induced a cascade of chemokine and cytokine secretion following in vitro culture of
pinna biopsy samples. While macrophage inflammatory protein 1 and interleukin-1 (IL-1) were produced
transiently within the first few days, the Th1-promoting cytokines IL-12 and IL-18 were secreted at high levels
until at least day 14. Assay of C3H/HeJ mice confirmed that IL-12 secretion was not due to lipopolysaccharide
contaminants binding Toll-like receptor 4. Significantly, IL-12 p40 secretion was sustained in pinnae from
vaccinated mice but not in those from nonprotected infected mice. In contrast, IL-10 was produced from both
vaccinated and infected mice. This cytokine regulates IL-12-associated dermal inflammation, since in vacci-
nated IL-10/ mice, pinna thickness was greatly increased concurrent with elevated levels of IL-12 p40. A
significant number of IL-12 p40 cells were detected as emigrants from in vitro-cultured pinnae, and most were
within a population of rare large granular cells that were Ia, consistent with their being antigen-presenting
cells. Labeling of IL-12 cells for CD11c, CD205, CD8, CD11b, and F4/80 indicated that the majority were
myeloid DCs, although a proportion were CD11c F4/80, suggesting that macrophages were an additional
source of IL-12 in the skin.
The processes leading to the induction of polarized T-helper
lymphocyte populations following exposure of the host to in-
fectious pathogens are believed to involve interactions between
the innate and acquired immune systems at the initial site of
infection (24). In this context, the skin is a major barrier across
which many infectious agents, including the parasitic helminth
Schistosoma mansoni, gain entry to the host. This site is pop-
ulated by an array of immune-competent accessory cells acting
as sentinels, which are an important source of cytokines and
chemokines responsible for amplifying the inflammatory re-
sponse by activating resident cells and recruiting additional
cells (9, 49). Cytokines also have an important influence on Th
cell development, with interleukin-12 (IL-12), IL-18, tumor
necrosis factor alpha, and IL-1 being key factors in the dif-
ferentiation of Th1 cells (20, 29).
In our study, we examined innate immune responses elicited
in the skin of mice exposed to radiation-attenuated (RA) lar-
vae of S. mansoni. In this vaccine model, RA larvae induce
Th1-type acquired immunity, which is characterized by the
persistence of gamma interferon (IFN-)-secreting Th cells in
the skin-draining lymph nodes (sdLN) (26) and confers 60 to
70% protection against a challenge infection (11). There is
clear evidence that IL-12 is a critical component of this Th1-
mediated protection (2, 47). In contrast, normal larvae fail to
support sustained production of IFN- in sdLN (30) and do
not induce significant levels of immunologically mediated pro-
tection (6, 45). Despite the obvious potential for interaction
between schistosomes and the innate immune system in the
skin, remarkably little is known about events at this site. It is
also unclear how RA and normal larvae differ in their effects
on the innate immune response and how this influences the
nature of the ensuing acquired immune response.
Schistosome cercariae are well adapted for infection of the
host by a percutaneous route (23). In murine skin, larvae
quickly reach the epidermal basement membrane by using
secretions from the pre- and postacetabular glands and remain
there for approximately 48 h prior to entering the dermis (44).
The parasites then exit via postcapillary venules, or lymphatic
vessels, with less than 25% of normal larvae remaining in the
skin by day 5 (25). In contrast, RA larvae exhibit severely
retarded migration from the skin (22, 25) and are well placed
to stimulate accessory cells of the innate immune response,
including antigen-presenting cells (APCs) (33). Although RA
larvae in the skin cause an increase in the thickness of the
epidermal and dermal layers (18, 44), secretion of cytokines in
the skin of vaccinated mice has never been studied despite its
likely relevance to the development of protective Th1-medi-
ated immunity.
The aim of our studies was to analyze the innate response to
RA larvae in order to define the cellular constituents and
cytokines in the skin that may promote a biased Th1-type
immune response. We show that the production of IL-12 p40
is a key feature of the innate response in the skin after expo-
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sure to RA larvae and that cells positive for dendritic cell (DC)
and macrophage markers are the source of this molecule.
Moreover, we report that RA larvae, contrary to previous
findings (32), induce the production of IL-10, which regulates
inflammation and the production of IL-12.
MATERIALS AND METHODS
Parasite and host. Female C57BL/6 mice (8 to 12 weeks old) were exposed to
500 RA (20-kilorad 60Co source) or normal S. mansoni cercariae via the pinna as
described in detail previously (27). By counting the nonpenetrant cercariae, we
determined that 65 to 75% of the applied cercariae successfully entered the
pinna and that the variation between individual mice for any vaccination was 5 to
10%. C3H/HeJ mice, which are hyporesponsive to lipopolysaccharide (LPS)
because of a genetic defect in Toll-like receptor 4 (TLR-4) (31), and their normal
C3H/HeN cohorts were obtained from Harlan United Kingdom Ltd. Protective
immunity in these two strains was determined following exposure to challenge
larvae (2). IL-12 p40/ (21) and IL-10/ (19) (Taconic Farms) mice were bred
and maintained alongside wild-type (WT; C57BL/6 background) cohorts at the
University of York. All animal work was carried out in accordance with the
guidelines of the United Kingdom Animals (Scientific Procedures) Act 1986.
Sampling regimen. On days 0 (naive), 1, 2, 4, 8, and 14 postvaccination (p.v.),
groups of mice (providing four to six pinnae) were killed and the extent of
inflammation was determined by measurement of pinna thickness with a dial
gauge micrometer (Mitutoyo). Pinnae were carefully removed to ensure that the
biopsy samples were of a consistent size and then prepared for culture in vitro or
histologic analysis.
Histologic analysis of dermal immune responses. For conventional histologic
analysis, pinnae were fixed in 10% neutral buffered formalin (Sigma), wax em-
bedded, sectioned at 6 m, and stained with hematoxylin and eosin (Eastalt
Histology Laboratories, Warrington, United Kingdom). For immunohistochem-
ical analysis, pinnae were embedded in OCT compound (H&E Ltd., Notting-
ham, United Kingdom), frozen with liquid N2, and then stored at 80°C prior to
sectioning at 7 m (Slee Cryostat) on poly-L-lysine-coated glass slides (Super-
frost Plus; Invitrogen, Paisley, United Kingdom). Sections were fixed in 3.7%
paraformaldehyde in phosphate-buffered saline (PBS) for 20 min, washed, and
air dried. Following rehydration in PBS, sections were incubated with 3% bovine
serum albumin and then endogenous peroxidase and biotin blocked with 1%
H2O2 in PBS for 15 min and a biotin blocking kit, respectively (Vector Labs,
Peterborough, United Kingdom). Sections were subsequently incubated with
unlabeled or biotinylated primary antibodies against cell surface markers (details
below) for 30 min at room temperature and then, when required, with a biotin-
ylated secondary antibody for 30 min at room temperature. For intracellular
IL-12 p40 staining, 0.1% saponin was incorporated at each incubation step after
fixing; sections were labeled with biotinylated anti-IL-12 p40 (C17.8; BD Phar-
Mingen, Oxford, United Kingdom). Immunostaining was completed with the
Vectastain Elite ABC peroxidase reagent combined with the Vector VIP or
NovaRED enzyme substrate and counterstained with methyl green or hematox-
ylin (Vector Labs).
In vitro culture of pinna biopsy samples and sdLN cells. Pinnae were cultured
in vitro with a technique adapted from that described by Belkaid et al. (4) as
described in detail elsewhere (27). Briefly, each pinna was split and floated on 0.5
ml of RPMI medium containing 10% fetal calf serum (low endotoxin; Seralab,
Oxon, United Kingdom), 2 mM L-glutamine, 200 U of penicillin per ml, and 100
g of streptomycin per ml (RPMI/10; Sigma, Poole, United Kingdom) in 24-well
hydrophobic culture plates (Greiner Labortechnik, Frickenhausen, Germany).
Pinnae were cultured in the absence of added parasite antigen for 6 to 18 h at
37°C in 5% CO2. Nonadherent cells were recovered from culture supernatants by
centrifugation at 800  g for 5 min, while loosely adherent cells were obtained
after incubation with Mg2- and Ca2-free PBS supplemented with 2 mg of
glucose per ml for 20 min at 37°C. Cells were pooled and resuspended in
phenobuffer (PBS containing 0.01% CaCl2, 0.01% MgCl2, and 0.1% bovine
serum albumin). Cells from sdLN of vaccinated and infected mice (n  5) were
recovered on days 4, 8, and 14 after exposure and cultured for 72 h in the
presence or absence of a soluble antigen preparation (50 g/ml) from larval
schistosomes (27). Cell-free supernatants from the dermal and sdLN cultures
were collected and frozen at 20°C prior to analysis by enzyme-linked immu-
nosorbent assay (ELISA). In all experiments, tissues from naive mice were
similarly prepared to establish baseline levels for immune responses.
Phenotypic analysis of cells from skin cultures. Aliquots of up to 5  105 cells
were incubated with anti-CD16/CD32 (0.25 g; BD PharMingen) to block Fc
receptors and then with optimum dilutions of antibodies against surface markers
for 30 min on ice. Different cell types were identified with antibodies against
surface markers as follows: hematopoietic cells, CD45 (M1-9.3HL; Sigma); ma-
jor histocompatibility complex class II APCs, Iab,d (B21.2; Caltag-MedSystems,
Towcester, United Kingdom); macrophages/myeloid cells, CD11b (Mac-1, M1/
70; Serotec) and F4-80 (C1:A3-1; Serotec); DCs, CD11c (N418; BD PharMin-
gen) and CD205 (NLDC-145; Serotec); lymphoid DCs, CD8 (53-6.7; BD
PharMingen). Antibodies were conjugated with fluorochromes (fluorescein iso-
thiocyanate or phycoerythrin) or biotin, in which case Streptavidin-QR (Serotec)
was used as a detection probe. Irrelevant isotype-matched antibodies were used
to determine levels of nonspecific binding. Labeled cells were then analyzed by
two-color flow cytometry (Coulter XL). For intracellular staining of IL-12 p40,
cells were cultured as described above but in the presence of 1 g of GolgiPlug
(BD PharMingen) per ml for 12 h to block cytokine secretion. After surface
staining, cells were treated with Cytofix/Cytoperm (BD PharMingen) and incu-
bated with phycoerythrin-labeled IL-12 p40 monoclonal antibody (MAb) (C15.6;
BD PharMingen) or a rat immunoglobulin G1 isotype control. At least 1,000
IL-12 events were analyzed for each sample.
Cytokine and chemokine ELISAs. Paired antibody capture ELISAs with a
biotinylated detection step were used to measure cytokines and chemokines in
dermal and sdLN culture supernatants as follows (all antibodies were from BD
PharMingen, except where specified otherwise): anti-IL-1MAb (30311) with an
anti-IL-1 polyclonal antibody (PAb) (both R&D Systems, Oxon, United King-
dom); an anti-IL-4 MAb (BVD4-1D11) with an anti-IL-4 MAb (BVD6-24G2);
an anti-IL-6 MAb (MP5-20F3) with an anti-IL-6 MAb (MP5-32C11); an anti-
IL-10 MAb (JES5 2A5) with an anti-IL-10 MAb (SXC-1); an anti-IL-12 p40
MAb (C15-6) with an anti-IL-12 p40 MAb (C17.8); and an anti-IFN- MAb
(R4-6A2) with an anti-IFN- MAb (XMG1.2). All biotinylated antibodies were
detected with streptavidin peroxidase conjugate. IL-18 was detected with an
rabbit anti-IL-18 PAb (gift from C. Locht, Institut Pasteur, Lille, France) with an
anti-IL-18 PAb (R&D Systems) detected with anti-goat peroxidase conjugate
(Sigma). Recombinant standards were IL-1, IL-10, IL-18 (R&D Systems), IL-6,
IL-4 (BD PharMingen), IFN- (211A CHO cell supernatant), and IL-12 (S.
Wolf, Genetics Institute, Cambridge, Mass.). The lower limits of detection were
100 pg/ml (IL-18), 25 pg/ml (IL-1 and IFN-), 20 pg/ml (IL-12 p40), 10 pg/ml
(IL-4 and IL-10), and 5 pg/ml (IL-6). Macrophage inflammatory protein 1
(MIP-1), MIP-1, and eotaxin were measured with Quantikine kits (R&D
Systems); the lower limit of detection was 5 pg/ml. Reactions were detected with
TMB substrate (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.) and
read at 630 nm (MRX II plate reader; Dynex Technologies, Billinghurst, United
Kingdom).
Statistics. Comparisons of data were tested for significance with Student’s t
test. (***, P 	 0.001; **, P 	 0.01; *, P 	 0.05; nonsignificant, P 
 0.05).
Arithmetic means  the standard error of the mean (SEM) are shown. The data
shown are representative of three to eight different experiments.
RESULTS
RA larvae elicit inflammation of the exposure site. Immedi-
ately following exposure to RA larvae, the site of exposure
increased in thickness, as measured with a gauge micrometer
at autopsy (day 1; 41.9%; P 	 0.001) and the thickness
continued to increase to a peak on day 4 before declining to
near baseline (naive) values by day 14 (Fig. 1a). Although
shrinkage occurred following sample preparation, the increase
in pinna thickness was also evident by histological analysis (Fig.
1b). Both the epidermis and dermis exhibited increased cellu-
larity, particularly between days 2 and 8. An influx of cells into
the dermis was apparent immediately after vaccination on ei-
ther side of the central zone of cartilage and by day 4 had
formed large foci, some surrounding parasites (e.g., day 4).
However, by day 14, the inflammatory response had largely
subsided, with only a residual cellular influx remaining.
RA larvae stimulate a cascade of inflammatory cytokines
and chemokines in dermal tissues. We first established that
the pattern of cytokine production detected at 6 and 18 h after
in vitro culture of pinnae did not differ, although quantitatively
more of each cytokine was produced by the latter sampling
time (data not shown); consequently, all of the data shown are
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for cytokine production at 18 h. Cytokine secretion is ex-
pressed per pinna, not on the basis of an arbitrary number of
cells, since it is more relevant to consider the total amount of
cytokine expressed at any particular time by the whole organ,
which would influence the immune priming process. One of
the first cytokines to be detected was IL-1, which increased
significantly by day 1 (P 	 0.01) above the level in naive skin
and peaked on day 2 (Fig. 2a). IL-1 was still elevated on day
4, although it declined to baseline levels by day 8. IL-6 was by
far the most abundant cytokine detected, even in cultures from
naive mice (Fig. 2b), but exposure to RA cercariae led to a
transient increase on day 1. Highly elevated levels of MIP-1
were also detected immediately after vaccination on days 1 and
2, which were followed by a decline to the baseline on day 8
(Fig. 2c). Production of MIP-1 too increased rapidly after
vaccination, but in this case, secretion remained elevated until
day 8 (Fig. 2d). The levels of eotaxin were low at all time
points, although they were significantly above the baseline until
day 4 (P 	 0.05; Fig. 2e).
Cytokines that are involved in the development of Th1 cell
populations were notable constituents of dermal supernatants
from vaccinated mice. Elevated levels of IL-12 p40 were re-
corded from day 1 (P 	 0.05), and production increased to a
plateau between days 2 and 8 (P 	 0.001; Fig. 2f). We were
unable to detect significant quantities of the p70 heterodimer
because it is present at levels 1,000-fold less than that of the
p40 molecule (S. J. Jenkins and A. P. Mountford, unpublished
data) and commercial ELISA reagents are insufficiently sensi-
tive to permit detection in our dermal supernatants. IL-18 was
also produced at significantly increased levels (P 	 0.001)
between days 2 and 8 (Fig. 2g). In contrast, very low levels of
IFN- were detected and only on days 4 and 8 (Fig. 2h). IL-4
secretion also remained at naive levels until days 4 and 8, when
there was an approximately twofold increase (Fig. 2i; P 	
0.01). Finally, IL-10, which may have an inhibitory effect on
cellular reactivity in the skin, was detected as early as day 1 (P
	 0.05), although peak values occurred later than for most
other monokines between days 4 and 8 (P 	 0.001; Fig. 2j).
IL-12 p40 secretion is sustained in vaccinated but not in-
fected mice. Analysis of a number of early-phase cytokines
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FIG. 1. Inflammation of the skin after exposure to RA larvae. (a) Pinna thickness at autopsy on days 1, 2, 4, 8, and 14 p.v. The data are means
 SEM for 8 to 10 pinnae. (b) Micrographs showing inflammatory reactions through transverse sections of pinnae stained with hematoxylin and
eosin. Scale bar, 50 m. The arrow indicates the position of a parasite.
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FIG. 2. Cytokine and chemokine production by in vitro-cultured
pinnae at 18 h obtained from naive mice and on days 1,2, 4, and 8 p.v.
Bars represent cytokine production in picograms or nanograms per
milliliter, which is equivalent to the total per pinna. Data are means 
SEM for four to six pinnae. Statistical significance is for data compared
to naive values. Horizontal dashed line shows the level of cytokine
production in naive mice.
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(e.g., IL-1, IL-6, MIP-1, and eotaxin) secreted by in vitro-
cultured skin biopsy samples showed that there was little or no
difference in the quantities detected by ELISA between mice
exposed to RA or normal larvae (data not shown). The most
obvious difference was in the sustained production of IL-12
p40 by pinnae from vaccinated mice, which was significantly
higher than for infected pinnae at every time point (Fig. 3a; P
	 0.01 and P 	 0.001). Moreover, the production of IL-12 p40
by infected pinnae declined from a peak on day 2, such that on
day 14, pinnae from vaccinated mice secreted more than three
times the amount produced by infected skin. In contrast, the
secretion of IL-18 by in vitro-cultured pinnae was not substan-
tially different between infected and vaccinated mice between
days 2 and 8; only on day 14 was the level of IL-18 slightly
higher for vaccinated mice (P 	 0.05; Fig. 3b). IL-10 was also
secreted by skin biopsy samples from both infected and vacci-
nated mice, although its production lagged behind that of
IL-12 p40 (Fig. 3c). In infected mice, peak values of IL-10 were
detected on day 4 before declining to the baseline values by day
14. In comparison, vaccinated pinnae secreted less IL-10 on
day 4 but its production persisted until at least day 8. More-
over, by day 14, the amount secreted by vaccinated pinnae was
significantly higher than that produced by infected pinnae.
A divergent pattern of cytokine secretion was also observed
in the supernatants from in vitro-cultured cells from the sdLN
of vaccinated mice compared to those of infected mice. Al-
though early on (day 4), there was no difference in the quan-
tities of IL-12 p40 produced by sdLN cells between the two
groups, the production of abundant IL-12 was sustained on
days 8 (P 	 0.01) and 14 (P 	 0.001) in the vaccinated group
but not in the infected group (Fig. 3d). Antigen-stimulated
production of IFN- by sdLN cells had a similar profile and
remained highly elevated in the vaccinated group on days 8 and
14, while in the infected group, secretion of IFN- quickly
declined and was hardly greater than naive levels by day 14
(Fig. 3e). Meanwhile, production of IL-4 declined rapidly from
a peak on day 4 in both groups of mice. These data show that
there is a strong Th1 bias in cytokine production in the sdLN
of vaccinated mice.
Inflammation and IL-12 production by dermal cells is reg-
ulated by the presence of IL-10. Since significant amounts of
IL-10 were produced by skin biopsy samples from vaccinated
mice, we examined its effect on inflammation and cytokine
production in vaccinated IL-10/ and IL-12 p40/ mice.
Inflammation of the skin on day 4, as judged by pinna thick-
ness, was significantly greater in IL-10/ mice than the in-
crease in either WT (normal) or IL-12 p40/ mice (P	 0.001;
Fig. 4a). Secretion of IL-12 p40 by skin biopsy samples ob-
tained from IL-10/ mice was also significantly greater (P 	
0.001) than that from pinnae of WT mice (Fig. 4b). Conversely,
secretion of IL-10 by pinnae from IL-12 p40/ mice was
highly elevated over the level in WT mice (P 	 0.001; Fig. 4d).
The production of IL-18 was not significantly different in IL-12
p40/ or IL-10/ mice compared to that in WT cohorts (P

0.05; Fig. 4c).
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IL-12 production in response to RA larvae is not dependent
on TLR-4. IL-12 p40 secretion was not significantly lower in the
culture supernatants from C3H/HeJ mice than that of their
normal C3H/HeN cohorts on day 2, 4, or 8 (all P 
 0.05; Fig.
5). No other cytokine tested differed between the two strains,
and the pinnae were similar in thickness (data not shown). The
mean worm burdens in vaccinated and challenged animals
were 45.4  4.2 for strain C3H/HeN and 40.2  6.1 for strain
C3H/HeJ, which were not significantly different (P 
 0.05).
Protective immunity was 63.2 and 66.7% for C3H/HeN and
C3H/HeJ mice, respectively.
Identification of IL-12 p40 cells in skin tissue. To identify
the source of IL-12 in the skin, immunohistochemical analysis
was used to identify the constituent cell types. The dermis of
C57BL/6 mice contains melanin, as shown by small brown
flecks in transverse cryosections of pinnae stained with a rep-
resentative antibody isotype control (Fig. 6a). Cells positive for
the neutrophil-specific marker 7/4 antigen (purple-black stain-
ing) were detected as early as day 2 p.v. adjacent to the epi-
dermis (data not shown), but the peak influx was detected on
day 4 (Fig. 6b). The density of CD11b cells in the cellular foci
appeared less than for 7/4 cells, and their distribution was
more dispersed (Fig. 6c), while CD11c cells were rare (Fig.
6d). We also observed zones of IL-12 cells in the dermis on
day 4 (red-pink staining in Fig. 6e), which colocalized with the
regions of greatest cellular infiltration. However, we were un-
able to accurately identify the phenotype of the individual
IL-12 p40 cells involved with peroxidase staining because of
the heterogeneity and close proximity of the cells within the
inflammatory foci. As an alternative, we opted to analyze cells
that spontaneously emigrate from cultured pinnae.
IL-12 p40 cells in the dermal exudate population are
CD11c and F4/80. Cells which detached from the pinnae
during in vitro culture were taken to be indicators of those that
contribute to dermal inflammation. They also indicate which
types are capable of migrating to the sdLN. No enzymes were
used to ensure that cell surface markers were not degraded.
By focusing on pinnae obtained on day 4 after vaccination
(approximate peak of cell efflux), we identified three groups of
cells in the exudate on the basis of size and granularity (Fig.
7a). Two populations, containing nearly 90% (16.1 and 71.6%)
of the cells, were both classified as small but differed in their
granularity; a third group comprising very large granular cells
(LGC) accounted for only 11.0% of the total (Fig. 7a). While
only 3.9% of the CD45 cell population was IL-12 (Fig. 7b
and c), nearly 70% of them were within the LGC population
(Fig. 7d). A smaller proportion (23%) of IL-12 cells was in
the small and granular population, while only 7.8% was in the
highly abundant but small nongranular population (Fig. 7d).
The flow cytometric scatter distribution of IL-12 p40 cells
based on their size and granularity is similar, regardless of the
day after exposure (i.e., 2, 4, or 8; data not shown). Moreover,
analysis of the results from several experiments (n  2 to 4)
showed that the percentage of all cells that were IL-12 re-
mained constant at all time points (day 2, 2.9%  0.4%; day 4,
3.4%  0.3%; day 8, 2.3%  0.7%). The proportions of LGC
that were IL-12 at different times were also very similar (day
2, 11.6% 0.6%; day 4, 12.2% 0.8%; day 8, 11.5% 1.2%).
Because of the low number of cells recoverable from naive
mice, it was not possible to accurately detect IL-12 cells in the
exudate population on day 0.
Analysis of the IL-12 cells that were present in the LGC
population showed that most were Ia on days 2, 4, and 8
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l
C3H HeN C3H HeJ
Days post-vaccination
FIG. 5. IL-12 p40 production by in vitro-cultured pinnae of vacci-
nated C3H/HeN (solid bars) and C3H/HeJ (cross-hatched bars) mice.
Data are means  SEM for four to six pinnae. Values of the two
strains are not statistically significantly different at any time point (P 

0.05).
a) Isotype
control
b) 7/4
d) CD11cc) CD11b
e) IL-12p40
FIG. 6. Immunohistochemical analysis of cellular influx into pinnae
on day 4 after vaccination. Micrographs of positive staining (Vector
VIP; black-purple) counterstained with methyl green illustrated by a
representative isotype control (a), the neutrophil marker 7/4 (b), the
macrophage marker CD11b (c), and the DC marker CD11c (d). (e)
Zones of IL-12 p40 cells colocalize with the cellular influx in the
dermis (pink-red; arrow). Melanin can be distinguished as a brown
marking in the upper dermis; see panel a. Scale bars, 50 m.
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(Table 1). A large number of IL-12 cells were also positive for
CD11c or CD205, which is supportive of the hypothesis that
most IL-12 cells were DCs. Less than 2% of the IL-12 cells
in the LGC population were CD8, but nearly all (
95%)
were CD11b, demonstrating that the DCs were myeloid and
not lymphoid (34). Further, we report that about two-thirds of
the IL-12 exudate population was positive for the macro-
phage marker F4/80; this molecule is present on some DCs
from the skin (14), and in our study, most CD11c cells in the
LGC region coexpressed F4/80 (80.3%; data not shown). How-
ever, approximately 40 to 50% of IL-12 cells were CD11c or
CD205. Since more than 95% of the IL-12 cells were
CD11b and most (63 to 74%) were F4/80, the IL-12
CD11c population may represent mature macrophages.
DISCUSSION
Our studies document, for the first time, the inflammatory
innate immune response and the cytokine profile in murine
skin exposed to RA schistosome larvae. We highlight the role
of IL-12 in the skin during the first 14 days, which is important
in the development of Th1-type immune responses. Despite
being the first site that encounters parasite antigen, the skin
has not previously been considered an important organ in-
volved in the initiation of immunity to schistosomes.
The influx of cells into the skin contributing to its increased
thickness is liable to be initiated by the secretion of chemo-
kines and cytokines detected immediately after vaccination.
The earliest molecules to be detected are three CC chemo-
kines, MIP-1 (CCL3), MIP-1 (CCL4), and eotaxin
(CCL11), all of which are released at peak levels within 24 h of
parasite exposure. MIP-1 and MIP-1 are attractants for
monocytes, lymphocytes, and immature DCs into the skin (36,
38, 48), and while the former chemokine is only expressed
transiently, production of the latter is maintained. Interest-
ingly, both MIP-1 and MIP-1 have been linked to the de-
velopment of Th1-type responses (10). These studies illustrate
the rapidity of the host’s response to parasite penetration
forming the initial step in the inflammatory cascade leading to
the transient production of acute-phase cytokines, such as
IL-1 and IL-6. Such cytokines are known to recruit additional
cells and direct the migration of some (e.g., Langerhans cells)
out of the skin (9, 43). Indeed, the greatest production of
chemokines and acute-phase cytokines occurs before the peak
of cell infiltration observed on days 4 to 8. In addition, these
FIG. 7. Flow cytometric analysis of dermal exudate cells. For a representative experiment, panel a illustrates the size (FS) and granularity (SS)
of the total unstained exudate cell population on day 4 p.v. composed of three major groupings of cells; percentages define the proportions of cells
within the three groups according to Quadstat analysis. An LGC population (circled) makes up 11% of the cells recovered. The total exudate
population double stained for CD45 (FL3) with intracellular IL-12 p40 (FL2) is shown in panel c, and CD45 with an intracellular isotype control
is shown in panel b. The distribution of IL-12 p40 cells on the basis of their size and granularity is shown in panel d; percentages define the
proportions of IL-12 p40 cells located within the three groups of cells by Quadstat analysis.
TABLE 1. Analysis of the surface of IL-12 p40 cells in
the LGC regiona
Phenotype Day 2 Day 4 Day 8
Ia 70.4  3.1 77.1 4.1 79.7b
CD11c 58.5 1.9 49.4 5.2 ND
CD205 60.1 3.3c 59.7  0.5c ND
CD8 	2.0 	2.0 ND
CD11b 96.4 3.8 97.8 4.1 94.7b
F4/80 63.3  2.4 67.7 3.7 74.4b
a The data shown are the mean percent positive  SEM from three or four
experiments. ND, not done.
b n  1.
c n  2.
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mediators are potent activators of candidate APCs by increas-
ing the expression of major histocompatibility complex class II
and aid the production of IL-12 and IL-18.
One of the major findings of our studies is that the skin is an
important site for the production of IL-12. The persistent pro-
duction of IL-12 p40 in the skin until day 14 is clearly condu-
cive to the promotion of IFN--secreting Th cells present in
the sdLN (26). Indeed, the absence of this molecule in IL-12
p40/ mice leads to the development of Th2-type responses
and a significant reduction in protective immunity (2). Al-
though the p40 molecule detected by ELISA may be an antag-
onist homodimer (p40)2 (12), others have reported that p40 in
the skin functions like the heterodimer (18). Another Th1-
inducing cytokine, IL-18, is also detected in the dermal super-
natants and is known to be produced by keratinocytes (37) and
Langerhans cells (42). It can act in concert with IL-12 and
other cytokines, such as IL-1, tumor necrosis factor alpha,
and IL-6, in the proinflammatory immune response (29). How-
ever, we show that IL-18 production is not diminished in IL-12
p40/ mice, which do not to develop Th1-type responses (2).
Moreover, the level of IL-18 production is similar in infected
and vaccinated mice, reinforcing the conclusion that IL-18
does not play a major role in aiding the generation of Th1 cells
in this model. The absence of significant secretion of IFN- in
the skin appears to rules out this cytokine (and, by implication,
natural killer cells as a possible source of early IFN-) as an
important factor in priming for a Th1-type response. Instead,
we conclude that sustained IL-12 p40 in the skin is an impor-
tant feature in protectively vaccinated mice. Indeed, in mice
exposed to normal (nonprotective) larvae, IL-12 production
p40 declines rapidly after the first few days, correlating with the
rapid exit of normal parasites from the skin (25). The transient
production of IL-12 p40 in the skin is undoubtedly a major
factor in the failure of infected mice to develop substantive and
persistent populations of IL-12 p40 APCs and IFN- CD4
cells in the sdLN and hence the inability of these mice to
develop a protective immune response.
One significant issue is whether IL-12 production is induced
by the parasite itself or a bacterial contaminant that may enter
the host’s skin following cercarial penetration. LPS binding to
TLR-4 is a major cause of IL-12 production by macrophages
and DCs (1). In this respect, C3H/HeJ strain mice have a
natural TLR-4 gene mutation and are unresponsive to LPS
(31). However, the production of IL-12 p40 by in vitro-cultured
pinnae from vaccinated mice is unaffected by the absence of
TLR-4 and protective immunity is not reduced, indicating that
TLR-4 is not responsible for the induction of IL-12 in our
model.
Another important cytokine produced by skin biopsy sam-
ples is IL-10. One theory is that, in contrast to normal para-
sites, RA larvae in the skin fail to induce immunoregulatory
prostaglandin E2 and IL-10 (32). Normal parasites are also
known to stimulate the production of prostaglandin D2 and
IL-7, which are implicated in the regulation of inflammatory
immune responses (3, 46). Since prostaglandin E2 inhibits
IL-12 production (40) via its effect on IL-10 (13), this could
restrict the development of Th1-type responses. However, our
data show that abundant IL-10 is secreted in response to RA
larvae. IL-10 clearly has an important immunoregulatory effect
since the skin of vaccinated IL-10/ mice was more inflamed
than normal (WT) and skin biopsy samples secreted much
higher levels of IL-12 p40. Therefore, IL-10 appears to protect
the host against an excess of IL-12 p40, which causes gross
inflammation of the skin. We concluded that, in normal vac-
cinated mice, the quantities of IL-10 are sufficient to regulate
dermal responses to an acceptable level but an excess, such as
in IL-12 p40/ mice, leads to no further dampening of in-
flammation. Since vaccinated IL-10/ and IL-12 p40/ mice
develop highly polarized Th1- and Th2-type responses, leading
to elevated and reduced levels of protection, respectively (2,
17), we conclude that the ability of RA larvae to induce Th1-
type responses in normal (WT) mice reflects the induction of a
fine balance between proinflammatory IL-12 and regulatory
IL-10 in the skin shortly after exposure rather than simply a
failure to induce IL-10.
A technically demanding but important aim of our studies
has been to identify the type of cell in the skin that is respon-
sible for IL-12 secretion. Small numbers of IL-12 p40 cells
were detected in the dermis, but it is not possible to identify
them on the basis of surface marker expression because of the
close apposition of different cell types within the foci. How-
ever, approximately 3% of the cells that emigrate from in
vitro-cultured pinnae are IL-12 p40 and although this value
may be thought low, IL-12 is a very potent cytokine in vivo.
Moreover, the significance of the IL-12 dermal exudate pop-
ulation is that it comprises cells capable of migrating to the
sdLN, where priming and differentiation of Th cells occur.
Neutrophils are among the most abundant cells in inflam-
matory foci, but although they can produce IL-12 (7), on a
per-cell basis, neutrophils produce less than monocytes (8) and
only a small number of IL-12 p40 cells in the dermal exudate
are detected within the small granular leukocyte (neutrophil)
population. On the other hand, most IL-12 cells are very
large and granular (i.e., LGC) and are Ia, which suggests that
they are antigen-experienced DCs and/or macrophages. In-
deed, although LGC represent only 11 to 12% of the total cell
exudate, nearly 70% of IL-12 cells occur within this popula-
tion. DCs are potent producers of IL-12, particularly the
CD8 lymphoid subset (15). However, we could not detect a
CD8 population of CD11c DCs; rather, the CD11c DCs
are CD11b, which is supportive of their being myeloid DCs.
In addition, a significant proportion of the CD11c cells in this
study is positive for F4/80, which is present on many dermal
exudate DCs (14). Therefore, although myeloid DCs are not
widely accepted as a potent source of IL-12, the data presented
here show that they represent the major population of IL-12
p40 cells in the dermal exudate. Such cells could be migrating
Langerhans cells from the epidermis since Langerhans cell-like
DCs produce IL-12 in response to leishmania infection (41).
Our results also support a role for F4/80 CD11c macro-
phages in the skin as a source of IL-12. Indeed, macrophages
stimulated by listeriae were among the first cell types identified
as a source of IL-12 (35). However, it is not known whether
IL-12 production is restricted to a specific type or class of
macrophages. For example, reductive macrophages are better
producers of IL-12 than are oxidative ones, which secrete IL-10
and IL-6 (28). Alternatively, the balance of IL-12 versus IL-10
may result from differences in the relative dominance of DCs
versus macrophages should they be the primary sources of
these two cytokines, respectively (16). The cellular source of
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the IL-10 in our model is not known, but it could derive from
keratinocytes (32), F4/80 Gr1 suppressor macrophages (39),
and/or regulatory T cells (5). Further studies on the dermal
sources of this cytokine will provide an important insight into
how cutaneous inflammation is controlled in this experimental
model and how this may be manipulated to enhance the prim-
ing of the acquired immune response.
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